Developer docs
API playgroundTry for free, no card

Search company profiles

ContRoL

Full company profile

uuid0006yng

Namestring
ContRoL
Legal namestring
NSERC CREATE Training Program for Controlled Release Leaders (ContRoL)
Company typeenum
Private
Founded yearint
2021
Descriptiontext

ContRoL (Controlled Release Leaders) is an NSERC CREATE training program hosted at McMaster University in Hamilton, Ontario, established in 2021 under the direction of Professor Todd Hoare. It is a grant-funded academic consortium, not a commercial enterprise, designed to equip Master's, Ph.D., and postdoctoral trainees with both technical and job-ready skills for developing next-generation controlled release vehicles. The program operates as a pan-Canadian network of 9 university partners, 9 industry partners, and 3 non-profit or government organizations, with NSERC providing primary funding through a $1.65 million, six-year grant (2021-2027).

The technical core spans the engineering of delivery vehicles — including hydrogels, liposomes, microparticles, polymer nanoparticles, microneedles, coacervates, triggerable vehicles, implantable devices, muco/tissue adhesives, and bioconjugates — that deliver active agents in a spatially and temporally controlled manner across pharmaceutical, food/nutraceutical, agriculture, medical device, and personal care applications. Recent advances the program integrates include smart materials, self-assembly, targeting, biomanufacturing, statistical optimization, machine learning, and high-throughput screening. The curriculum combines integrative courses (Collaborative Design in Controlled Release; Leadership for Innovation) with design sprints, where solutions are validated with industry and potential customer input, plus industry placements, career mentoring, mentorship circles, entrepreneurship modules, scientific communications training, and lab exchanges.

The business model is grant-based rather than revenue-generating: NSERC CREATE funding covers trainee stipends, internships, communications training, and program administration, while industry partners contribute co-op positions, mentorship, and hands-on training without paying fees. The program's "deliverables" are trained scientists and collaborative research outputs rather than commercial products or services, with trainee recruitment handled by investigators and a program coordinator across partner universities and partnership growth driven through an inquiry form, an Annual General Meeting, and joint events with the Canadian Chapter of the Controlled Release Society.

Short descriptiontext

ContRoL is an NSERC CREATE training program at McMaster University that equips Master's, Ph.D., and postdoctoral trainees with technical and industry-ready skills to develop next-generation controlled release vehicles, operating across a pan-Canadian consortium of 9 universities, 9 industry partners, and 3 non-profit/government organizations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHamilton, Canada
HQ citystring
Hamilton
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
controlled release technology, graduate research training, drug delivery science, biomaterials engineering, academic workforce development
Industry1 code
PRIMARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code1 code
  • Professional and Management Development Training611430
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Graduate Research Training Program
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1NSERC CREATE Grant Funding
TypeLicensing Royalties
Description

The primary funding source is a $1.65 million grant awarded by the Natural Sciences and Engineering Research Council of Canada (NSERC) CREATE program. This grant supports research and training in controlled release technology over a six-year period, supplementing students' academic experience with internships, communications training, and other career-ready skills.

brighterworld.mcmaster.ca
2Industry Partnership Contributions
TypeProfessional Services
Description

Industry partners participate by providing co-op positions, on-site hands-on training experiences, mentorship, and collaborative research projects. While partners may help attract partial or full funding subsidies for trainee positions, the program does not charge partners for participation — this is a training cost-sharing model rather than a revenue-generating commercial model.

control-create.mcmaster.ca
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ContRoL (Controlled Release Leaders) is an NSERC CREATE Training Program that recruits Master's students, Ph.D. candidates, and postdoctoral fellows across nine Canadian partner universities to develop next-generation controlled release vehicles. The program combines technical training in delivery vehicles (hydrogels, liposomes, microparticles, polymer nanoparticles, microneedles, coacervates, implantable devices, and bioconjugates) with professional skills training, industry placements, design sprints, and entrepreneurship modules for applications spanning pharmaceutical, food/nutraceuticals, agriculture, medical devices, and personal care industries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Trainees complete industry placements as an integrated part of their graduate program, gaining hands-on experience outside academia.
+2 more records
Product overview1 text field

The NSERC CREATE ContRoL Training Program is a unified training platform that combines multiple components to develop controlled release technology expertise. The core program includes integrative courses ('Collaborative Design in Controlled Release' and 'Leadership for Innovation'), supplemented by Design Sprints for customer-validated solutions, Industry Placements for practical experience, Career Mentoring, a Mentorship Circle connecting trainees with industry leaders, Entrepreneurship Modules, Scientific Communications Training, Industry Skills Workshops, and Lab Exchanges. The program serves Master's students, Ph.D. students, Post-Doctoral Fellows, and Summer Undergraduate students across nine partner universities in Canada, with the goal of producing graduates equipped to lead the development of controlled release vehicles for pharmaceutical, personal care, medical devices, agriculture, and food/nutraceuticals applications.

Product and service1 record
1NSERC CREATE ContRoL Training Program
CategoryGraduate Research Training
Description

A six-year graduate training program (2021-2027) that equips Master's, Ph.D., and Post-Doctoral trainees with technical and professional skills to design, fabricate, and translate next-generation controlled release vehicles for pharmaceutical, personal care, medical devices, agriculture, and food/nutraceuticals applications across nine partner Canadian universities.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

McMaster University is the lead institution and headquarters of the ContRoL program. Todd Hoare, Professor and Canada Research Chair in Engineered Smart Materials at McMaster's Department of Chemical Engineering, serves as Program Director. The program is administered from McMaster's campus in Hamilton, Ontario.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

McGill University is a university partner in the ContRoL network. Marta Cerruti, Associate Professor of Materials Engineering and co-Director of the McGill Institute for Advanced Materials, represents McGill as a ContRoL investigator.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Guelph is a university partner. Iris Joye, Associate Professor of Cereal Chemistry and Biochemistry, serves as a ContRoL investigator contributing expertise in food science applications of controlled release technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Waterloo is a university partner. Emmanuel Ho, Associate Professor at the School of Pharmacy and Department of Chemical Engineering, represents Waterloo as a ContRoL investigator.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Toronto is a university partner. Shirley Wu, Professor at the Leslie Dan Faculty of Pharmacy, serves as a ContRoL investigator.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ontario Tech University is a university partner. Hendrick de Haan, Associate Professor in the Department of Physics, represents Ontario Tech as a ContRoL investigator.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Carleton University is a university partner. Maria DeRosa, Professor and Department Chair of Chemistry, represents Carleton as a ContRoL investigator.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

INRS is a university partner based in Montreal. Marc Gauthier, Full Professor at the EMT Research Center, serves as a ContRoL investigator.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Université de Montréal is a university partner. Davide Brambilla, Assistant Professor at the Faculté de Pharmacie, represents UdeM as a ContRoL investigator.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Ripple Therapeutics is an industry partner in the ContRoL program, participating as a mentor and providing hands-on training experiences for trainees. Focus areas include developing innovative controlled release solutions in the pharmaceutical space.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

20/20 OptimEyes is an industry partner contributing expertise in ophthalmic applications of controlled release technology. Participates in mentorship, co-op positions, and collaborative research projects.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

GreenMark Biomedical is an industry partner focused on biomedical and dental applications of controlled release. Engages with ContRoL trainees through mentorship and collaborative research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sollio Agriculture is an industry partner contributing to precision agriculture applications within the ContRoL program. Provides industry perspective and hands-on training opportunities in agricultural controlled release technologies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Pharmasonica is an industry partner providing industry discovery activities, placement opportunities, and mentorship for ContRoL trainees in the pharmaceutical space.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Mannin Research is an industry partner engaged in collaborative research within the ContRoL controlled release network, contributing biotechnological expertise.

16Suncor
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Suncor is an industry partner participating in the ContRoL training program, providing industry exposure and potential training experiences for trainees.

control-create.mcmaster.ca
Strategic tierMinorTypeStrategic or Co-development Partner
Description

AmacaThera is an industry partner providing co-op and hands-on training experiences within the ContRoL network, with a focus on pharmaceutical applications of controlled release technology.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Nanology Labs is an industry partner participating as a mentor and collaborator within the ContRoL training program, contributing pharmaceutical nanotechnology expertise.

19Canadian Chapter of the Controlled Release Society (CC-CRS)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CC-CRS is a non-profit partner that collaborates with ContRoL to organize national workshops and networking events, providing partner organizations with national exposure and trainees with professional community connections.

control-create.mcmaster.ca
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Agriculture and Agri-Food Canada is a government partner contributing to the ContRoL network, with particular relevance to agricultural and food/nutraceutical applications of controlled release technology.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

An industry partner in the ContRoL network and a clinical-stage ophthalmology company developing controlled release therapeutics. Directly comparable as a Canadian controlled release company that benefits from ContRoL's talent pipeline and research collaboration.

TypeDirect peer
Description

An industry partner in the ContRoL network developing injectable controlled release hydrogel platforms for pharmaceutical applications. Comparable as a Canadian pharma company leveraging advanced controlled release vehicles, a core subject area of the ContRoL training program.

TypeDirect peer
Description

An industry partner in the ContRoL network developing biomedical and dental applications of controlled release technology. Comparable as a startup commercializing controlled release for medical device and dental indications, overlapping with ContRoL's biomedical segment focus.

TypeDirect peer
Description

An industry partner in the ContRoL network focused on pharmaceutical nanotechnology. Comparable as a Canadian company developing nanoparticle-based drug delivery, intersecting directly with ContRoL's polymer nanoparticle and microneedle training content.

TypeDirect peer
Description

An industry partner in the ContRoL network engaged in collaborative biotech research. Comparable as a Canadian biotechnology company participating in the ContRoL consortium for biotechnological applications of controlled release.

TypeBroad incumbent
Description

A commercial-stage U.S. pharmaceutical company specializing in non-opioid pain management and other therapeutics using proprietary controlled release technology. Comparable as an established, commercial controlled release drug delivery company at much greater scale than ContRoL's industry partners.

TypeBroad incumbent
Description

A global specialty chemicals company with a significant pharmaceutical contract development and drug delivery business, including sustained and controlled release excipients. Comparable as a large incumbent operating across multiple controlled release applications including pharma, food, and agriculture.

8Selecta Biosciences
TypeDirect peer
Description

A clinical-stage biotechnology company developing controlled release immunotherapies using synthetic vaccine particle technology. Comparable as a focused controlled release therapeutics developer, intersecting with ContRoL's pharmaceutical training segment.

TypeBroad incumbent
Description

A global specialty chemicals company with a healthcare-focused drug delivery business supplying excipients and formulation technologies for controlled release. Comparable as a large, established player in controlled release technology across pharma and personal care end-markets.

TypeDirect peer
Description

An industry partner in the ContRoL network contributing expertise in ophthalmic applications of controlled release technology. Comparable as a Canadian partner that ContRoL engages with for co-op positions, mentorship, and collaborative research in ophthalmic drug delivery.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ContRoL

Graduate Research Training Programcontrol-create.mcmaster.ca

ContRoL is an NSERC CREATE training program at McMaster University that equips Master's, Ph.D., and postdoctoral trainees with technical and industry-ready skills to develop next-generation controlled release vehicles, operating across a pan-Canadian consortium of 9 universities, 9 industry partners, and 3 non-profit/government organizations.

What ContRoL does

ContRoL (Controlled Release Leaders) is an NSERC CREATE training program hosted at McMaster University in Hamilton, Ontario, established in 2021 under the direction of Professor Todd Hoare. It is a grant-funded academic consortium, not a commercial enterprise, designed to equip Master's, Ph.D., and postdoctoral trainees with both technical and job-ready skills for developing next-generation controlled release vehicles. The program operates as a pan-Canadian network of 9 university partners, 9 industry partners, and 3 non-profit or government organizations, with NSERC providing primary funding through a $1.65 million, six-year grant (2021-2027).

The technical core spans the engineering of delivery vehicles — including hydrogels, liposomes, microparticles, polymer nanoparticles, microneedles, coacervates, triggerable vehicles, implantable devices, muco/tissue adhesives, and bioconjugates — that deliver active agents in a spatially and temporally controlled manner across pharmaceutical, food/nutraceutical, agriculture, medical device, and personal care applications. Recent advances the program integrates include smart materials, self-assembly, targeting, biomanufacturing, statistical optimization, machine learning, and high-throughput screening. The curriculum combines integrative courses (Collaborative Design in Controlled Release; Leadership for Innovation) with design sprints, where solutions are validated with industry and potential customer input, plus industry placements, career mentoring, mentorship circles, entrepreneurship modules, scientific communications training, and lab exchanges.

The business model is grant-based rather than revenue-generating: NSERC CREATE funding covers trainee stipends, internships, communications training, and program administration, while industry partners contribute co-op positions, mentorship, and hands-on training without paying fees. The program's "deliverables" are trained scientists and collaborative research outputs rather than commercial products or services, with trainee recruitment handled by investigators and a program coordinator across partner universities and partnership growth driven through an inquiry form, an Annual General Meeting, and joint events with the Canadian Chapter of the Controlled Release Society.

ContRoL firmographics

Firmographics
Name
ContRoL
Legal name
NSERC CREATE Training Program for Controlled Release Leaders (ContRoL)
Website
https://control-create.mcmaster.ca
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
ContRoL is an NSERC CREATE training program at McMaster University that equips Master's, Ph.D., and postdoctoral trainees with technical and industry-ready skills to develop next-generation controlled release vehicles, operating across a pan-Canadian consortium of 9 universities, 9 industry partners, and 3 non-profit/government organizations.
Ownership category
akta.pro rank

ContRoL industry classification

Industry
Product category
Graduate Research Training Program
NAICS
Professional and Management Development Training (611430)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Controlled release technology
  • Graduate research training
  • Drug delivery science
  • Biomaterials engineering
  • Academic workforce development

Where ContRoL is headquartered

Location

Headquarters

HQ city
Hamilton
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

ContRoL business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

  1. NSERC CREATE Grant Funding: The primary funding source is a $1.65 million grant awarded by the Natural Sciences and Engineering Research Council of Canada (NSERC) CREATE program. This grant supports research and training in controlled release technology over a six-year period, supplementing students' academic experience with internships, communications training, and other career-ready skills.
  2. Industry Partnership Contributions: Industry partners participate by providing co-op positions, on-site hands-on training experiences, mentorship, and collaborative research projects. While partners may help attract partial or full funding subsidies for trainee positions, the program does not charge partners for participation — this is a training cost-sharing model rather than a revenue-generating commercial model.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

ContRoL product offering

Product offering

Core offering

ContRoL (Controlled Release Leaders) is an NSERC CREATE Training Program that recruits Master's students, Ph.D. candidates, and postdoctoral fellows across nine Canadian partner universities to develop next-generation controlled release vehicles. The program combines technical training in delivery vehicles (hydrogels, liposomes, microparticles, polymer nanoparticles, microneedles, coacervates, implantable devices, and bioconjugates) with professional skills training, industry placements, design sprints, and entrepreneurship modules for applications spanning pharmaceutical, food/nutraceuticals, agriculture, medical devices, and personal care industries.

Product overview

The NSERC CREATE ContRoL Training Program is a unified training platform that combines multiple components to develop controlled release technology expertise. The core program includes integrative courses ('Collaborative Design in Controlled Release' and 'Leadership for Innovation'), supplemented by Design Sprints for customer-validated solutions, Industry Placements for practical experience, Career Mentoring, a Mentorship Circle connecting trainees with industry leaders, Entrepreneurship Modules, Scientific Communications Training, Industry Skills Workshops, and Lab Exchanges. The program serves Master's students, Ph.D. students, Post-Doctoral Fellows, and Summer Undergraduate students across nine partner universities in Canada, with the goal of producing graduates equipped to lead the development of controlled release vehicles for pharmaceutical, personal care, medical devices, agriculture, and food/nutraceuticals applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • NSERC CREATE ContRoL Training Program A six-year graduate training program (2021-2027) that equips Master's, Ph.D., and Post-Doctoral trainees with technical and professional skills to design, fabricate, and translate next-generation controlled release vehicles for pharmaceutical, personal care, medical devices, agriculture, and food/nutraceuticals applications across nine partner Canadian universities.

Quantifiable outcome

  • Trainees complete industry placements as an integrated part of their graduate program, gaining hands-on experience outside academia.
  • +2 more outcomes

Companies that use ContRoL

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles2 records

ContRoL technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

ContRoL partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered core and minor.

  • McMaster UniversitycoreStrategic or Co-development PartnerMcMaster University is the lead institution and headquarters of the ContRoL program. Todd Hoare, Professor and Canada Research Chair in Engineered Smart Materials at McMaster's Department of Chemical Engineering, serves as Program Director. The program is administered from McMaster's campus in Hamilton, Ontario.
  • McGill UniversitycoreStrategic or Co-development PartnerMcGill University is a university partner in the ContRoL network. Marta Cerruti, Associate Professor of Materials Engineering and co-Director of the McGill Institute for Advanced Materials, represents McGill as a ContRoL investigator.
  • University of GuelphcoreStrategic or Co-development PartnerUniversity of Guelph is a university partner. Iris Joye, Associate Professor of Cereal Chemistry and Biochemistry, serves as a ContRoL investigator contributing expertise in food science applications of controlled release technology.
  • University of WaterloocoreStrategic or Co-development PartnerUniversity of Waterloo is a university partner. Emmanuel Ho, Associate Professor at the School of Pharmacy and Department of Chemical Engineering, represents Waterloo as a ContRoL investigator.
  • University of TorontocoreStrategic or Co-development PartnerUniversity of Toronto is a university partner. Shirley Wu, Professor at the Leslie Dan Faculty of Pharmacy, serves as a ContRoL investigator.
  • Ontario Tech UniversitycoreStrategic or Co-development PartnerOntario Tech University is a university partner. Hendrick de Haan, Associate Professor in the Department of Physics, represents Ontario Tech as a ContRoL investigator.
  • Carleton UniversitycoreStrategic or Co-development PartnerCarleton University is a university partner. Maria DeRosa, Professor and Department Chair of Chemistry, represents Carleton as a ContRoL investigator.
  • Institut national de la recherche scientifique (INRS)coreStrategic or Co-development PartnerINRS is a university partner based in Montreal. Marc Gauthier, Full Professor at the EMT Research Center, serves as a ContRoL investigator.
  • Université de MontréalcoreStrategic or Co-development PartnerUniversité de Montréal is a university partner. Davide Brambilla, Assistant Professor at the Faculté de Pharmacie, represents UdeM as a ContRoL investigator.
  • Ripple TherapeuticsminorStrategic or Co-development PartnerRipple Therapeutics is an industry partner in the ContRoL program, participating as a mentor and providing hands-on training experiences for trainees. Focus areas include developing innovative controlled release solutions in the pharmaceutical space.
  • 20/20 OptimEyesminorStrategic or Co-development Partner20/20 OptimEyes is an industry partner contributing expertise in ophthalmic applications of controlled release technology. Participates in mentorship, co-op positions, and collaborative research projects.
  • GreenMark BiomedicalminorStrategic or Co-development PartnerGreenMark Biomedical is an industry partner focused on biomedical and dental applications of controlled release. Engages with ContRoL trainees through mentorship and collaborative research.
  • Sollio AgricultureminorStrategic or Co-development PartnerSollio Agriculture is an industry partner contributing to precision agriculture applications within the ContRoL program. Provides industry perspective and hands-on training opportunities in agricultural controlled release technologies.
  • PharmasonicaminorStrategic or Co-development PartnerPharmasonica is an industry partner providing industry discovery activities, placement opportunities, and mentorship for ContRoL trainees in the pharmaceutical space.
  • Mannin ResearchminorStrategic or Co-development PartnerMannin Research is an industry partner engaged in collaborative research within the ContRoL controlled release network, contributing biotechnological expertise.
  • SuncorminorStrategic or Co-development PartnerSuncor is an industry partner participating in the ContRoL training program, providing industry exposure and potential training experiences for trainees.
  • AmacaTheraminorStrategic or Co-development PartnerAmacaThera is an industry partner providing co-op and hands-on training experiences within the ContRoL network, with a focus on pharmaceutical applications of controlled release technology.
  • Nanology LabsminorStrategic or Co-development PartnerNanology Labs is an industry partner participating as a mentor and collaborator within the ContRoL training program, contributing pharmaceutical nanotechnology expertise.
  • Canadian Chapter of the Controlled Release Society (CC-CRS)coreStrategic or Co-development PartnerCC-CRS is a non-profit partner that collaborates with ContRoL to organize national workshops and networking events, providing partner organizations with national exposure and trainees with professional community connections.
  • Agriculture and Agri-Food CanadaminorStrategic or Co-development PartnerAgriculture and Agri-Food Canada is a government partner contributing to the ContRoL network, with particular relevance to agricultural and food/nutraceutical applications of controlled release technology.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

ContRoL competitors and assessment

Company assessment

Direct peers

  • Ripple Therapeutics: An industry partner in the ContRoL network and a clinical-stage ophthalmology company developing controlled release therapeutics. Directly comparable as a Canadian controlled release company that benefits from ContRoL's talent pipeline and research collaboration.
  • AmacaThera: An industry partner in the ContRoL network developing injectable controlled release hydrogel platforms for pharmaceutical applications. Comparable as a Canadian pharma company leveraging advanced controlled release vehicles, a core subject area of the ContRoL training program.
  • GreenMark Biomedical: An industry partner in the ContRoL network developing biomedical and dental applications of controlled release technology. Comparable as a startup commercializing controlled release for medical device and dental indications, overlapping with ContRoL's biomedical segment focus.
  • Nanology Labs: An industry partner in the ContRoL network focused on pharmaceutical nanotechnology. Comparable as a Canadian company developing nanoparticle-based drug delivery, intersecting directly with ContRoL's polymer nanoparticle and microneedle training content.
  • Mannin Research: An industry partner in the ContRoL network engaged in collaborative biotech research. Comparable as a Canadian biotechnology company participating in the ContRoL consortium for biotechnological applications of controlled release.
  • Selecta Biosciences: A clinical-stage biotechnology company developing controlled release immunotherapies using synthetic vaccine particle technology. Comparable as a focused controlled release therapeutics developer, intersecting with ContRoL's pharmaceutical training segment.
  • 20/20 OptimEyes: An industry partner in the ContRoL network contributing expertise in ophthalmic applications of controlled release technology. Comparable as a Canadian partner that ContRoL engages with for co-op positions, mentorship, and collaborative research in ophthalmic drug delivery.

Broad incumbents

  • Pacira BioSciences: A commercial-stage U.S. pharmaceutical company specializing in non-opioid pain management and other therapeutics using proprietary controlled release technology. Comparable as an established, commercial controlled release drug delivery company at much greater scale than ContRoL's industry partners.
  • Evonik Industries: A global specialty chemicals company with a significant pharmaceutical contract development and drug delivery business, including sustained and controlled release excipients. Comparable as a large incumbent operating across multiple controlled release applications including pharma, food, and agriculture.
  • Croda International: A global specialty chemicals company with a healthcare-focused drug delivery business supplying excipients and formulation technologies for controlled release. Comparable as a large, established player in controlled release technology across pharma and personal care end-markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

ContRoL social profiles

Digital presence

ContRoL financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ContRoL leadership team

Management profile

Number of profiles

Profiles1 record

ContRoL funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ContRoL M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ContRoL

What does ContRoL do?

ContRoL (Controlled Release Leaders) is an NSERC CREATE Training Program that recruits Master's students, Ph.D. candidates, and postdoctoral fellows across nine Canadian partner universities to develop next-generation controlled release vehicles. The program combines technical training in delivery vehicles (hydrogels, liposomes, microparticles, polymer nanoparticles, microneedles, coacervates, implantable devices, and bioconjugates) with professional skills training, industry placements, design sprints, and entrepreneurship modules for applications spanning pharmaceutical, food/nutraceuticals, agriculture, medical devices, and personal care industries.

Is ContRoL a public or private company?

ContRoL is a private company. It is classified as state government owned and is currently operating.

When was ContRoL founded?

ContRoL was founded in 2021. It employs 1 to 10 people.

Where is ContRoL based?

ContRoL is headquartered in Hamilton, Canada, in the North America region.

How does ContRoL make money?

Two revenue lines are on record. NSERC CREATE Grant Funding is the primary driver. The others are industry Partnership Contributions.

Who are ContRoL's main competitors?

Direct peers on record are Ripple Therapeutics, AmacaThera, GreenMark Biomedical, Nanology Labs, Mannin Research, Selecta Biosciences and 20/20 OptimEyes. Broad incumbents are Pacira BioSciences, Evonik Industries and Croda International.

Does ContRoL have an API?

No public API is recorded for ContRoL.

What industry is ContRoL in?

ContRoL's product category is Graduate Research Training Program. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 611430 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals